GlassScriptPhysician profile
Tobias Bepler
NPI 1366914053
$4,030.07
in general payments reported to CMS, 2019-2025
40 companies · $1,658 in 2025
The $1,658 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $783 · 2024: $1,590 · 2025: $1,658.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,924 · Education: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,924.08 |
| Education | $105.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $579.60 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $254.51 | 2023-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $244.50 | 2023-2025 | Xtandi |
| Convatec INC. | $238.96 | 2023-2025 | |
| Accord Healthcare, INC. | $193.77 | 2023-2025 | |
| Teleflex LLC | $192.61 | 2024-2025 | Urolift |
| Medtronic, INC. | $184.23 | 2023-2025 | Interstim, Altaviva |
| Dendreon Pharmaceuticals LLC | $158.29 | 2024-2025 | Provenge |
| Myriad Genetic Laboratories, INC. | $150.90 | 2023-2025 | Prolaris |
| Janssen Scientific Affairs, LLC | $149.38 | 2023-2025 | Erleada, Pipeline |
| Antares Pharma, INC. | $129.32 | 2024-2025 | Xyosted |
| Valencia Technologies Corporation | $125.00 | 2025 | Ecoin Device Kit |
| Coloplast Corp | $114.31 | 2023 | |
| Olympus America INC. | $111.16 | 2024-2025 | Itind System |
| Urogen Pharma, INC. | $101.99 | 2024-2025 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $98.79 | 2023-2025 | |
| Endo USA, INC. | $91.05 | 2024-2025 | Xiaflex, Aveed |
| Ferring Pharmaceuticals INC. | $86.08 | 2024-2025 | Adstiladrin |
| Blue Earth Diagnostics | $85.09 | 2024-2025 | Posluma |
| Verity Pharmaceuticals INC. | $80.68 | 2025 | Trelstar |
| Procept Biorobotics Corporation | $57.03 | 2024-2025 | Aquabeam System |
| Edap Technomed INC | $55.94 | 2025 | |
| Boston Scientific Corporation | $51.82 | 2024 | |
| Sun Pharmaceutical Industries INC. | $50.00 | 2024 | |
| Tolmar, INC. | $48.08 | 2023-2025 | Jatenzo, Eligard |
| Laborie Medical Technologies Corp. | $43.29 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Pfizer INC. | $37.71 | 2024 | |
| Halozyme INC | $37.36 | 2023 | |
| Progenics Pharmaceuticals, INC. | $33.87 | 2023-2024 | Pylarify |
| Astrazeneca Pharmaceuticals LP | $33.15 | 2024-2025 | Lynparza |
| Merck Sharp & Dohme LLC | $31.63 | 2024 | Lynparza |
| Avyxa Pharma, LLC | $29.24 | 2025 | |
| Heron Therapeutics, INC. | $22.23 | 2023 | Zynrelef |
| Bioprotect Medical, INC. | $21.96 | 2024 | Bioprotect Balloon Implant System |
| Immunitybio, INC. | $21.66 | 2025 | |
| Novartis Pharmaceuticals Corporation | $20.27 | 2023 | |
| Photocure INC | $18.57 | 2024 | Cysview |
| Genzyme Corporation | $17.12 | 2023 | |
| Axonics, INC. | $15.22 | 2023 | Axonics |
| Telix Pharmaceuticals | $13.70 | 2023 | Illuccix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tobias Bepler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.